Premium
The role of adenosine A1 receptors in the nucleus accumbens during morphine withdrawal
Author(s) -
Jafarova Demirkapu Mahluga,
Yananlı Hasan Raci,
Kaleli Melisa,
Sakalli Halil Eren,
Gören Mehmet Zafer,
Topkara Betilay
Publication year - 2020
Publication title -
clinical and experimental pharmacology and physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 103
eISSN - 1440-1681
pISSN - 0305-1870
DOI - 10.1111/1440-1681.13224
Subject(s) - nucleus accumbens , (+) naloxone , agonist , dopamine , morphine , opioid , pharmacology , drug withdrawal , chemistry , medicine , adenosine , physical dependence , endocrinology , receptor , drug
Abstract Opioids are effective analgaesic agents, but serious adverse effects such as tolerance and withdrawal contribute to opioid dependence and limit their use. Opioid withdrawal is a common occurrence in human opiate addicts that is not life‐threatening. Studies have shown that the mesocorticolimbic system, especially the nucleus accumbens, is an important region in drug addiction and adenosine receptors play a modulatory role in the mechanism of action of drug dependence and withdrawal. The aim of this study was to investigate the effects of the selective A 1 receptor agonist CPA (N 6 ‐cyclopentyladenosine) on withdrawal symptoms, and the concentration of dopamine and noradrenaline in the nucleus accumbens and locomotor activity behaviour during naloxone‐precipitated withdrawal in morphine‐dependent rats. The local administration of CPA (1.5, 3.0, and 6.0 mmol/L bilateral 250 nL) into the nucleus accumbens decreased the Gellert–Holtzman withdrawal scale, and increased concentrations of dopamine and noradrenaline in the same region during naloxone‐induced withdrawal. Our findings suggest that administration of the A 1 receptor agonist significantly decreased withdrawal behaviours and increased dopamine and noradrenaline concentrations in opioid withdrawal in a dose‐dependent manner. These results demonstrate that adenosine receptors should be examined as a potential mechanism that could be exploited for the treatment of morphine withdrawal.